Infinitus — AI Agents for Pharmaceutical Provider Engagement and Medical Affairs Updated 2026
ENTITYInfinitus has launched AI agents designed to help pharmaceutical teams reach more healthcare providers and support medical affairs functions. These agents automate outreach, information provision, and relationship management tasks that traditionally require human medical science liaisons and sales representatives. The AI agents operate across multiple communication channels to engage providers with relevant clinical information, trial enrollment opportunities, and product education. This represents a shift from traditional pharma-provider engagement models toward agentic AI systems that can operate with greater autonomy in managing relationships and information flow. The approach aims to extend the reach of pharmaceutical companies' medical affairs efforts and reduce the time burden on providers for information-seeking. The deployment of AI agents in pharmaceutical provider engagement raises questions about transparency, conflict of interest disclosure, and the appropriate role of AI in clinical decision-support contexts. Providers need to understand when they're interacting with AI systems versus human representatives, and pharmaceutical companies must ensure that AI agents accurately represent clinical evidence and company positions without misleading providers about drug safety or efficacy. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.